Meningococcal Vaccines Market

Meningococcal Vaccines Market (Polysaccharide, Conjugate, Combination and Men B Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

  • Rep Id : TMRGL1666
  • Published On : May 2015
  • No. of Pages : 117
  • Category : Pharmaceutical

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.4 List of Abbreviations
1.5 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Meningococcal Vaccines Market (2013 & 2022)
2.2 Global Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
2.3 Comparative Analysis: Global Meningococcal Vaccines Market, by Geography, 2013 & 2022 (Value %)
 
Chapter 3 Global Meningococcal Vaccines Market Overview
3.1 Introduction
     3.1.1 Meningococcal Disease
            3.1.1.1 Risk Factors for Meningococcal Disease
            3.1.1.2 Clinical Features
                      3.1.1.2.1 Clinical Manifestations of Meningococcal Disease
            3.1.1.3 Epidemiology
            3.1.1.4 Diagnosis & Treatment
     3.1.2 Types of Meningococcal Vaccines
             3.1.2.1 Major Marketed Meningococcal Vaccines
3.2 Regulatory Scenario
     3.2.1 Meningococcal Vaccines in Pipeline
3.3 Market Drivers
     3.3.1 Developing economies reshaping global health and development
     3.3.2 Education and awareness through various non-profit organizations
     3.3.3 Travel vaccines for meningococcal disease
3.4 Market Restraints
     3.4.1 Disparate age groups and dosage regimen for routine immunization, and unpredictable and dynamic epidemiology of meningococcal disease
     3.4.2 Maintenance of cold chains to deliver vaccines leading to high cost of vaccination
3.5 Market Opportunities
     3.5.1 Development of vaccines through collaborations and public private partnerships making vaccines more affordable
     3.5.2 Novel approaches to improve the stability of meningococcal vaccines
     3.5.3 Developing halal vaccines
3.6 Event Impact Analysis
3.7 Porter’s Five Force Analysis for the Global Meningococcal Vaccines Market
     3.7.1 Bargaining Power of Suppliers
     3.7.2 Bargaining Power of Buyers
     3.7.3 Threat of Substitutes
     3.7.4 Threat of New Entrants
     3.7.5 Competitive Rivalry
3.8 Market Attractiveness Analysis for the Global Meningococcal Vaccines Market, by Geography
 
Chapter 4 Global Meningococcal Vaccines Market, by Type
4.1 Introduction
     4.1.1 Global Meningococcal Vaccines Market Revenue, by Type, 2012 - 2022 (USD Million)
4.2 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2013 & 2022 (Value %)
     4.2.1 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2013 & 2022
4.3 Polysaccharide Meningococcal Vaccines
     4.3.1 Global Polysaccharide Vaccines Market Revenue, by Brand, 2012 - 2022 (USD Million)
     4.3.2 Menomune
             4.3.2.1 Global Menomune Market Revenue, 2012 - 2022 (USD Million)
     4.3.3 Mencevax
            4.3.3.1 Global Mencevax Market Revenue, 2012 – 2022 (USD Million)
     4.3.4 NmVac4-A/C/Y/W-135
            4.3.4.1 Global NmVac4 Market Revenue, 2012 – 2022 (USD Million)
     4.3.5 Others (Bi Meningo, Quadri Meningo)
            4.3.5.1 Global Other Polysaccharide Vaccines Market Revenue, 2012 – 2022 (USD Million)
4.4 Conjugate Meningococcal Vaccines
     4.4.1 Global Conjugate Vaccines Market Revenue, by Brand, 2012 – 2022 (USD Million)
     4.4.2 Menactra
            4.4.2.1 Global Menactra Market Revenue, 2012 – 2022 (USD Million)
     4.4.3 Menveo
            4.4.3.1 Global Menveo Market Revenue, 2012 – 2022 (USD Million)
     4.4.4 NeisVac-C
            4.4.4.1 Global NeisVac-C Market Revenue, 2012 – 2022 (USD Million)
     4.4.5 Nimenrix
            4.4.5.1 Global Nimenrix Market Revenue, 2012 – 2022 (USD Million)
     4.4.6 Meningitec
            4.4.6.1 Global Meningitec Market Revenue, 2012 – 2022 (USD Million)
     4.4.7 Menjugate (Meningococcal Group C- CRM197 Conjugate Vaccine)
            4.4.7.1 Global Menjugate Market Revenue, 2012 – 2022 (USD Million)
     4.4.8 MenAfriVac
            4.4.8.1 Global MenAfriVac Market Revenue, 2012 – 2022 (USD Million)
     4.4.9 NmVac4-A/C/Y/W-135-DT (Nm-Vac4-DT)
            4.4.9.1 Global NmVac4 DT Market Revenue, 2016 – 2022 (USD Million)
4.5 Combination Meningococcal Vaccines
     4.5.1 Global Combination Vaccines Market Revenue, by Brand, 2012 - 2022 (USD Million)
     4.5.2 MenHibrix
            4.5.2.1 Global MenHibrix Market Revenue, 2014 – 2022 (USD Million)
     4.5.3 Menitorix
            4.5.3.1 Global Menitorix Market Revenue, 2012 - 2022 (USD Million)
4.6 Meningococcal B Vaccines
     4.6.1 Bexsero
            4.6.1.1 Global Bexsero Market Revenue, 2014 - 2022 (USD Million)
     4.6.2 Trumenba (MnB rLP2806)
            4.6.2.1 Global Trumenba Market Revenue, 2015 - 2022 (USD Million)
 
Chapter 5 Global Meningococcal Vaccines Market, by Geography
5.1 Introduction
     5.1.1 Global Meningococcal Vaccines Market Revenue, by Geography, 2012 - 2022 (USD Million)
5.2 North America
     5.2.1 North America Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)
     5.2.2 U.S.
            5.2.2.1 U.S. Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
     5.2.3 Canada
            5.2.3.1 Canada Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
5.3 Europe
     5.3.1 Europe Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)
     5.3.2 U.K.
             5.3.2.1 U.K. Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
     5.3.3 Germany
             5.3.3.1 Germany Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
     5.3.4 Rest of Europe
             5.3.4.1 Rest of Europe Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
5.4 Asia-Pacific
     5.4.1 Asia Pacific Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)
     5.4.2 Japan
            5.4.2.1 Japan Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
     5.4.3 Australia
            5.4.3.1 Australia Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
     5.4.4 Rest of Asia Pacific
             5.4.4.1 Rest of Asia Pacific Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
5.5 Rest of the World
     5.5.1 Rest of the World Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)
     5.5.2 Latin America
            5.5.2.1 Latin America Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
     5.5.3 Africa
            5.5.3.1 Africa Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
     5.5.4 Rest of RoW
            5.5.4.1 Rest of RoW Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 6 Competitive Landscape
6.1 Market Share by Key Players, 2013 (Value %)
     6.1.1 Methodology
     6.1.2 Analysis
 
Chapter 7 Recommendations
7.1 Focus on Low Cost of Manufacturing
7.2 Developing Animal Component Free and Halal Vaccines
7.3 Tapping Emerging Markets
7.4 Collaborating With Community Pharmacies
 
Chapter 8 Company Profiles
8.1 Baxter International, Inc.
     8.1.1 Company Overview
     8.1.2 Financial Overview
     8.1.3 Product Portfolio
     8.1.4 Business Strategies
     8.1.5 Recent Developments
8.2 Biomed Pvt., Ltd.
     8.2.1 Company Overview
     8.2.2 Financial Overview
     8.2.3 Product Portfolio
     8.2.4 Business Strategies
     8.2.5 Recent Developments
8.3 GlaxoSmithKline plc
     8.3.1 Company Overview
     8.3.2 Financial Overview
     8.3.3 Product Portfolio
     8.3.4 Business Strategies
     8.3.5 Recent Developments
8.4 JN-International Medical Corporation
     8.4.1 Company Overview
     8.4.2 Financial Overview
     8.4.3 Product Portfolio
     8.4.4 Business Strategies
     8.4.5 Recent Developments
8.5 Nuron Biotech, Inc.
     8.5.1 Company Overview
     8.5.2 Financial Overview
     8.5.3 Product Portfolio
     8.5.4 Business Strategies
     8.5.5 Recent Developments
8.6 Pfizer, Inc.
     8.6.1 Company Overview
     8.6.2 Financial Overview
     8.6.3 Product Portfolio
     8.6.4 Business Strategies
     8.6.5 Recent Developments
8.7 Sanofi SA
     8.7.1 Company Overview
     8.7.2 Financial Overview
     8.7.3 Product Portfolio
     8.7.4 Business Strategies
     8.7.5 Recent Developments
8.8 Serum Institute of India, Ltd.
     8.8.1 Company Overview
     8.8.2 Financial Overview
     8.8.3 Product Portfolio
     8.8.4 Business Strategies
     8.8.5 Recent Developments

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Meningococcal Vaccines Market (2013 & 2022)
TABLE 3 Major Marketed Meningococcal Vaccines
TABLE 4 Meningococcal Vaccines in Pipeline
TABLE 5 Event Impact Analysis
TABLE 6 Global Meningococcal Vaccines Market Revenue, by Type, 2012 - 2022 (USD Million)
TABLE 7 Global Polysaccharide Vaccines Market Revenue, by Brand, 2012 – 2022 (USD Million)
TABLE 8 Global Conjugate Vaccines Market Revenue, by Brand, 2012 – 2022 (USD Million)
TABLE 9 Global Combination Vaccines Market Revenue, by Brand, 2012 - 2022 (USD Million)
TABLE 10 Global Meningococcal Vaccines Market Revenue, by Geography, 2012 - 2022 (USD Million)
TABLE 11 North America Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)
TABLE 12 Europe Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)
TABLE 13 Asia Pacific Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)
TABLE 14 Rest of the World Meningococcal Vaccines Market Revenue, by Country, 2012 - 2022 (USD Million)

List of Figures
 
FIG. 1 Global Meningococcal Vaccines Market Segmentation
FIG. 2 Global Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 3 Comparative Analysis: Global Meningococcal Vaccines Market Revenue, by Geography, 2013 & 2022 (Value %)
FIG. 4 Risk Factors for Meningococcal Disease
FIG. 5 Clinical Manifestations of Meningococcal Disease
FIG. 6 Porter’s Five Forces Analysis: Global Meningococcal Vaccines Market
FIG. 7 Market Attractiveness Analysis: Global Meningococcal Vaccines Market, by Geography
FIG. 8 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2013 & 2022 (Value %)
FIG. 9 Global Menomune Market Revenue, 2012 – 2022 (USD Million)
FIG. 10 Global Mencevax Market Revenue, 2012 – 2022 (USD Million)
FIG. 11 Global NmVac4 Market Revenue, 2012 – 2022 (USD Million)
FIG. 12 Global Other Polysaccharide Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 13 Global Menactra Market Revenue, 2012 – 2022 (USD Million)
FIG. 14 Global Menveo Market Revenue, 2012 – 2022 (USD Million)
FIG. 15 Global NeisVac-C Market Revenue, 2012 – 2022 (USD Million)
FIG. 16 Global Nimenrix Market Revenue, 2012 – 2022 (USD Million)
FIG. 17 Global Meningitec Market Revenue, 2012 – 2022 (USD Million)
FIG. 18 Global Menjugate Market Revenue, 2012 – 2022 (USD Million)
FIG. 19 Global MenAfriVac Market Revenue, 2012– 2022 (USD Million)
FIG. 20 Global NmVac4 DT Market Revenue, 2016 – 2022 (USD Million)
FIG. 21 Global MenHibrix Market Revenue, 2014 – 2022 (USD Million)
FIG. 22 Global Menitorix Market Revenue, 2012 – 2022 (USD Million)
FIG. 23 Global Bexsero Market Revenue, 2014 – 2022 (USD Million)
FIG. 24 Global Trumenba Market Revenue, 2015 – 2022 (USD Million)
FIG. 25 U.S. Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 26 Canada Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 27 U.K. Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 28 Germany Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 29 Rest of Europe Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 30 Japan Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 31 Australia Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 32 Rest of Asia Pacific Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 33 Latin America Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 34 Africa Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 35 Rest of RoW Meningococcal Vaccines Market Revenue, 2012 – 2022 (USD Million)
FIG. 36 Market Share Analysis: Global Meningococcal Vaccines Market, 2013 (Value %)
FIG. 37 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 38 GlaxoSmithKline plc: Annual Revenue, by Segment, 2011 – 2013 (USD Million)
FIG. 39 Pfizer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 40 Sanofi SA: Annual Revenue, by Segment, 2011 – 2013 (USD Million)